DS-2325a
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DS-2325a, covering 2025-01-20 to 2025-01-20. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Explore Safety, Pharmacokinetics, and Early Clinical Signal of Efficacy of DS-2325a in Patients With Netherton Syndrome [Phase 1, Phase 2]